Usher syndrome is the most common form of combined congenital deaf-blindness in humans and affects 1 in 6,000 of the population. It is a recessive inherited disease that is both clinically and genetically heterogeneous. In the most severe cases, patien…
Month: July 2011
Treatment Approach To Human Usher Syndrome
New treatment approach shall soon be ready for use in Usher syndrome patients / Publication in “Human Gene Therapy”. Usher syndrome is the most common form of combined congenital deaf-blindness in humans and affects 1 in 6,000 of the population. It is …
Ranibizumab Improves Diabetic Macular Edema
Preplanned subanalysis shows that ranibizumab injection improves vision in patients with diabetic macular edema, regardless of glucose level control. Medscape Medical News
Drug Delivery Device Uses Magnets to Treat Diabetic Retinopathy
Diabetic retinopathy is a complication of diabetes mellitus that can eventually lead to blindness. Current treatments are not the terribly effective or reliable. For example, drugs in the form of eye drops often have a lower than desirable rate of diffusion into the eye, as well as potential systemic side effects. And, for obvious reasons, most pat (Read more...)
The World’s First 3D LASIK AND Tennessee’s First 3D Cataract Surgery Performed
Dr. Ming Wang of Wang Vision Cataract & LASIK Center, Nashville, TN, became the first surgeon in the world to perform a 3D LASIK procedure, and the first in Tennessee to perform a 3D cataract surgery. The first such ground-breaking surgeries took place…
The World’s First 3D LASIK AND Tennessee’s First 3D Cataract Surgery Performed
Dr. Ming Wang of Wang Vision Cataract & LASIK Center, Nashville, TN, became the first surgeon in the world to perform a 3D LASIK procedure, and the first in Tennessee to perform a 3D cataract surgery. The first such ground-breaking surgeries took place…
New Drug Delivery Device Invented To Treat Diabetes-Related Vision Loss
A team of engineers and scientists at the University of British Columbia has developed a device that can be implanted behind the eye for controlled and on-demand release of drugs to treat retinal damage caused by diabetes. Diabetic retinopathy is the l…
Scil Proteins Signs Licensing And Pre Manufacturing Agreement With Anabasis/Dompé For Eye Indications
Scil Proteins, a private biopharmaceutical company specialized in the research, development and production of recombinant proteins, today announced that it has signed an agreement with Anabasis Pharma.
Celebrating 30 Million Optomap® Patients Around The World
LONDON, UK, 29 June 2011 – Optos plc (LSE: OPTS), a leading medical retinal imaging company, announced that it reached an important milestone for its ultra-widefield retinal imaging product line – capturing images for 30 million optomap patients.
Scil Proteins Signs Licensing And Pre Manufacturing Agreement With Anabasis/Dompé For Eye Indications
Scil Proteins, a private biopharmaceutical company specialized in the research, development and production of recombinant proteins, today announced that it has signed an agreement with Anabasis Pharma.